Holen Sie sich die Stockscreener-App
2.13
4.27%
-0.095
Handel nachbörslich:
2.19
0.06
+2.82%
Schlusskurs vom Vortag:
$2.225
Offen:
$2.21
24-Stunden-Volumen:
614.21K
Relative Volume:
1.81
Marktkapitalisierung:
$248.89M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-13.73M
KGV:
-16.38
EPS:
-0.13
Netto-Cashflow:
$-3.92M
1W Leistung:
-8.58%
1M Leistung:
+43.92%
6M Leistung:
+187.84%
1J Leistung:
+56.62%
1-Tages-Spanne:
$2.06
$2.21
1-Wochen-Bereich:
$2.06
$2.53
52-Wochen-Spanne:
$0.6295
$2.60
Tiziana Life Sciences Ltd Stock (TLSA) Company Profile
Firmenname
Tiziana Life Sciences Ltd
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie TLSA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TLSA
Tiziana Life Sciences Ltd
|
2.13 | 287.45M | 0 | -13.73M | -3.92M | -0.13 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Tiziana Life Sciences Ltd Stock (TLSA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-12-22 | Eingeleitet | B. Riley Securities | Buy |
| 2018-12-17 | Eingeleitet | Laidlaw | Buy |
Tiziana Life Sciences Ltd Aktie (TLSA) Neueste Nachrichten
Smart tools for monitoring Tiziana Life Sciences Ltd’s price actionPortfolio Value Summary & High Accuracy Trade Signal Alerts - Newser
Will Tiziana Life Sciences Ltd stock benefit from interest rate changes2025 Earnings Surprises & Technical Pattern Recognition Alerts - Newser
Can Tiziana Life Sciences Ltd hit a new high this monthCapital Protection Strategy With Risk Analysis - Newser
Analyzing Tiziana Life Sciences Ltd with multi timeframe chartsShort-Term Support and Resistance Forecast - Newser
Top chart patterns to watch in Tiziana Life Sciences LtdBuy/Sell Zone Confirmation Technical Analysis - Newser
Multi factor analysis applied to Tiziana Life Sciences LtdFree Growth Based Stock Signal Screener - Newser
What moving averages say about Tiziana Life Sciences Ltd [Trade Analysis Report]Free Real-Time Buy Signal Notifications - Newser
Should you hold or exit Tiziana Life Sciences Ltd nowNear-Term Market Opportunity Forecast Sheet - Newser
Tiziana Life Sciences Ltd (TLSA) Stock: A Year of Decreases and Increases - investchronicle.com
Has Tiziana Life Sciences Ltd formed a bullish divergenceEquity Market Return Forecast Model Update - Newser
Tiziana Life’s Phase IIa multiple system atrophy study gets FDA approval - Yahoo Finance
How to interpret RSI for Tiziana Life Sciences Ltd stockPredictable Return Plan with Entry Guidance - Newser
What high frequency data says about ENDRA Life Sciences Inc.Entry and Exit Strategy for Swing Traders - Newser
What analysts say about Tiziana Life Sciences Ltd stock outlookDaily Technical Forecast for Quick Gains - Newser
FDA Approves Tiziana Life Sciences Phase 2 IND for Multiple System Atrophy - Informazione.it
Proactive financial news: fast, accessible, and actionable articles and videos for the global investment audience. - Proactive financial news
Market movers: Micron, Barrick, Tiziana Life Sciences, American Resources... - Proactive financial news
What moving averages say about Tiziana Life Sciences LtdSteady Return Plan Based on Data Analysis - Newser
Tiziana Life Sciences Phase 2a multiple system atrophy study green-lit by FDA - Proactive financial news
Tiziana to begin testing foralumab in multiple system atrophy - Seeking Alpha
Tiziana Life Sciences Announces FDA Approval of IND for Phase 2a Clinical Trial of Intranasal Foralumab in Multiple System Atrophy Patients - Quiver Quantitative
FDA Green-Lights Revolutionary Nasal Spray Treatment for Fatal Brain Disease Multiple System Atrophy - Stock Titan
Tiziana shares climb on FDA nod to test foralumab for multiple system atrophy - Proactive financial news
Applying sector rotation models to Tiziana Life Sciences LtdFree Risk Controlled Short Term Trade Plans - Newser
How to monitor Tiziana Life Sciences Ltd with trend dashboardsValue Holding Return Summary With Outlook - Newser
Detecting support and resistance levels for Tiziana Life Sciences LtdFree Value Investing Picks With Stability - Newser
Why Tiziana Life Sciences Ltd stock attracts strong analyst attentionSteady Return Plan Based on Data Analysis - Newser
Using economic indicators to assess Tiziana Life Sciences Ltd potentialCapital Growth Summary Over Five Years - Newser
Screener Results Flag Tiziana Life Sciences Ltd as OversoldSecure Capital Picks With Upside Potential Tracked - beatles.ru
Tesla: The Robotaxi Revolution Begins In Austin (TLSA) - Seeking Alpha
Is Tiziana Life Sciences Ltd stock a growth or value playFree Breakout Confirmation With Entry Tracker - Newser
What makes Tiziana Life Sciences Ltd stock price move sharplySmart Forecast Signals from AI Models - Newser
Should I hold or sell Tiziana Life Sciences Ltd stock in 2025Consistently outstanding ROI - Jammu Links News
What catalysts could drive Tiziana Life Sciences Ltd stock higher in 2025Powerful profit generation - Jammu Links News
What analysts say about Tiziana Life Sciences Ltd stockFind the best stocks for sustainable growth - Jammu Links News
Is it the right time to buy Tiziana Life Sciences Ltd stockTriple-digit wealth increases - Jammu Links News
How volatile is Tiziana Life Sciences Ltd stock compared to the marketInvest confidently with real-time data analysis - Jammu Links News
What is the risk reward ratio of investing in Tiziana Life Sciences Ltd stockAchieve rapid portfolio growth with expert help - Jammu Links News
What are Tiziana Life Sciences Ltd company’s key revenue driversMarket-beating performance - Jammu Links News
Is Tiziana Life Sciences Ltd stock overvalued or undervaluedGet real-time alerts on top stocks - Jammu Links News
When is Tiziana Life Sciences Ltd stock expected to show significant growthAchieve superior returns through strategic trading - Jammu Links News
What are the latest earnings results for Tiziana Life Sciences LtdAchieve breakthrough growth with proven strategies - Jammu Links News
Is Tiziana Life Sciences Ltd a growth stock or a value stockAchieve consistent profits with smart trading - Jammu Links News
What are analysts’ price targets for Tiziana Life Sciences Ltd in the next 12 monthsStrongest growth potential - Jammu Links News
What institutional investors are buying Tiziana Life Sciences Ltd stockDiscover stocks with explosive potential - Jammu Links News
Finanzdaten der Tiziana Life Sciences Ltd-Aktie (TLSA)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):